HighTower Advisors, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 123 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,000
-50.0%
12,0750.0%0.00%
Q2 2022$2,000
-94.7%
12,075
-83.8%
0.00%
Q1 2022$38,000
+111.1%
74,355
+163.9%
0.00%
Q4 2021$18,000
-79.1%
28,175
-82.2%
0.00%
Q3 2021$86,000
+65.4%
158,104
+108.0%
0.00%
Q2 2021$52,000
-38.8%
76,004
+205.2%
0.00%
Q1 2021$85,000
+142.9%
24,905
-32.7%
0.00%
Q3 2020$35,00037,0040.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 291,500$137,0000.14%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$441,0000.14%
CVA Family Office, LLC 1,137,920$535,0000.13%
Cypress Capital Management LLC (WY) 179,525$84,0000.10%
Willis Investment Counsel 2,075,840$976,0000.05%
NTB Financial Corp 146,100$69,0000.05%
SRS Capital Advisors, Inc. 629,172$296,0000.04%
Helen Stephens Group, LLC 117,222$55,0000.04%
COURIER CAPITAL LLC 464,356$218,0000.02%
Western Wealth Management, LLC 946,800$444,0000.02%
View complete list of AMPIO PHARMACEUTICALS INC shareholders